ATHA
Price
$4.18
Change
+$0.24 (+6.09%)
Updated
Mar 4, 12:20 PM EST
66 days until earnings call
CRSP
Price
$81.11
Change
-$2.64 (-3.15%)
Updated
Mar 4, 1:01 PM EST
57 days until earnings call
Ad is loading...

Compare predictions ATHA vs CRSP

Header iconATHA vs CRSP Comparison
Open Charts ATHA vs CRSPBanner chart's image
Athira Pharma
Price$4.18
Change+$0.24 (+6.09%)
Volume$1.42K
CapitalizationN/A
CRISPR Therapeutics AG
Price$81.11
Change-$2.64 (-3.15%)
Volume$300
CapitalizationN/A
View a ticker or compare two or three
ATHA vs CRSP Comparison Chart

Loading...

ATHADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ATHA vs. CRSP commentary
Mar 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Hold and CRSP is a Hold.

COMPARISON
Comparison
Mar 04, 2024
Stock price -- (ATHA: $3.94 vs. CRSP: $83.75)
Brand notoriety: ATHA and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 52% vs. CRSP: 64%
Market capitalization -- ATHA: $151.01M vs. CRSP: $6.72B
ATHA [@Biotechnology] is valued at $151.01M. CRSP’s [@Biotechnology] market capitalization is $6.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ATHA is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 5 TA indicator(s) are bullish.

  • ATHA’s TA Score: 5 bullish, 4 bearish.

Price Growth

ATHA (@Biotechnology) experienced а +0.25% price change this week, while CRSP (@Biotechnology) price change was -0.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.33%. For the same industry, the average monthly price growth was +19.10%, and the average quarterly price growth was +52.85%.

Reported Earning Dates

ATHA is expected to report earnings on May 09, 2024.

CRSP is expected to report earnings on Apr 30, 2024.

Industries' Descriptions

@Biotechnology (+4.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ATHA with price predictions.
OPEN
A.I.dvisor published
a Summary for CRSP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRSP($6.72B) has a higher market cap than ATHA($151M). ATHA YTD gains are higher at: 62.140 vs. CRSP (33.786). ATHA has higher annual earnings (EBITDA): -125.97M vs. CRSP (-202.7M). CRSP has more cash in the bank: 1.69B vs. ATHA (147M). ATHA has less debt than CRSP: ATHA (1.59M) vs CRSP (239M). CRSP has higher revenues than ATHA: CRSP (370M) vs ATHA (0).
ATHACRSPATHA / CRSP
Capitalization151M6.72B2%
EBITDA-125.97M-202.7M62%
Gain YTD62.14033.786184%
P/E RatioN/A20.92-
Revenue0370M-
Total Cash147M1.69B9%
Total Debt1.59M239M1%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHA
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
68%
View a ticker or compare two or three
Ad is loading...
ATHADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JRARX72.330.92
+1.29%
Janus Henderson Research R
OAIEX12.220.13
+1.08%
Optimum International A
JFGAX11.480.10
+0.88%
JHancock Fundamental Global Fran A
NGDRX26.600.19
+0.72%
Neuberger Berman Large Cap Growth R3
CRFIX10.910.06
+0.55%
Calvert Focused Value I

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with OCUL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+2.34%
OCUL - ATHA
41%
Loosely correlated
+6.86%
NUVB - ATHA
39%
Loosely correlated
+19.25%
CRSP - ATHA
38%
Loosely correlated
-0.56%
ALNY - ATHA
35%
Loosely correlated
+1.01%
ATNM - ATHA
34%
Loosely correlated
-0.70%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been loosely correlated with SANA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRSP jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-0.56%
SANA - CRSP
59%
Loosely correlated
+12.25%
AGIO - CRSP
54%
Loosely correlated
-0.15%
SGMO - CRSP
52%
Loosely correlated
-4.31%
DNA - CRSP
51%
Loosely correlated
-15.13%
AXON - CRSP
49%
Loosely correlated
+2.24%
More